Connect Biopharma Holdings Inc (CNTB) Actualités

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Attovia Therapeutics Appoints Chief Financial Officer

FREMONT, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Attovia Therapeutics announced the appointment of Steven...

Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024

SAN DIEGO, CA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update

Announced new U.S.-based leadership with the appointment of Barry Quart, Pharm.D. as Chief Executive Officer...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

Form SC 13D - General statement of acquisition of beneficial ownership

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]